Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc (NYSE:PFE) and the Trump administration to lower prescription drug prices.
What To Know: While the deal directly involves Pfizer, it serves as a crucial indicator for the entire industry, easing investor concerns about potential government-enforced price controls and tariffs. This uncertainty has long suppressed valuations for drugmakers and biotech firms.
